Accel Instruments and GSI (Gesellschaft fur Schwerionenforschung) are partnering with Siemens Medical Solutions to develop technology for delivering particle therapy. Accel, headquartered in Bergisch Gladbach, Germany, has more than 20 years' experience
Accel Instruments and GSI (Gesellschaft fur Schwerionenforschung) are partnering with Siemens Medical Solutions to develop technology for delivering particle therapy. Accel, headquartered in Bergisch Gladbach, Germany, has more than 20 years' experience in particle accelerator technology. GSI is a government-funded heavy ion research center located in Darmstadt, Germany. Particle therapy treatments utilize fast-moving atomic particles such as ions or protons. Treatments can be focused with pinpoint accuracy, thereby lowering integral dose and reducing toxicity to healthy tissues.
New MRI Research Explores Links Between Waist-to-Hip Ratio and Memory in Aging
March 13th 2025Researchers found that a higher waist-to-hip ratio in midlife was associated with higher mean diffusivity in 26 percent of total white matter tracts in the cingulum as well as the superior and inferior longitudinal fasciculus.
Can Ultrasound-Based Radiomics Enhance Differentiation of HER2 Breast Cancer?
March 11th 2025Multicenter research revealed that a combined model of clinical factors and ultrasound-based radiomics exhibited greater than a 23 percent higher per patient-level accuracy rate for identifying HER2 breast cancer than a clinical model.